AstexFold and generative AI models for structure-based discovery

Otsuka Holdings' Integrated Report 2026 states that Astex is using a proprietary dataset of more than 19,000 protein-ligand complexes to develop computational co-folding capabilities called AstexFold and generative AI models for fragment-based and structure-based drug design. The report also mentions the Pyramid platform integrating AI/ML methods. This is company self-reported, and the report does not state a deployment stage.